Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
Condition: Infantile Hemangioma Interventions: Drug: Propranolol three times a day; Drug: Propranolol twice a day; Drug: Timolol Sponsor: The University of Texas Health Science Center, Houston Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hemangioma | Inderal | Research | Science | Sleep Disorders | Sleep Medicine | Texas University | Timolol